PharmaShots | Incisive News in 3 Shots

Subscribe Now

Unclassifiable

Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

March 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us